08 August 2012 08:11 [Source: ICIS news]
SINGAPORE (ICIS)--Linde’s has completed the tender offer for all outstanding shares of common stock of US-based Lincare at $41.50 (€33.62) per share in cash, the German industrial gas supplier said on Wednesday.
The tender expired on 7 August as scheduled and was not extended, the company said in a statement.
“Linde intends to complete the acquisition of Lincare through a short-form merger without a vote or meeting of Lincare's shareholders,” it said.
Linde earlier last month said that it has entered into a definitive agreement to fully acquire medical gases and respiratory healthcare firm Lincare for $4.6bn.
Upon completion of the merger, Lincare will become a wholly owned indirect subsidiary of Linde, it added.
($1 = €0.81)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections